Abiopharma

🔍 WIGGANS THOMAS G (Director)

Company: Pacira BioSciences, Inc. (PCRX)

Report Date: 2026-06-10

Detailed Transactions and Holdings:

• Acquired 32,675 shares of Stock Option (Right to Buy) at $23.42 per share (Derivative)
  Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 32,675.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The stock option vests and becomes exercisable as to one-third of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal monthly installments over the subsequent two years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.